Aura Biosciences (AURA) Gains from Investment Securities (2021 - 2026)
Aura Biosciences (AURA) reported Gains from Investment Securities of $1.1 million for Q1 2026, up 479.16% quarter-over-quarter from $194000.0 in Q4 2025.
Aura Biosciences (AURA) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Aura Biosciences has reported Gains from Investment Securities for 6 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 327.21% YoY), and the FY2025 full-year result was $6.5 million, up 17.12% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $1.1 million, up from $194000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $6.0 million in Q2 2024, with the low at -$313000.0 in Q3 2022.
- Historically, Gains from Investment Securities has averaged $1.2 million across 5 years, with a median of $546722.5 in 2023.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 118930.57% — and 2023, when it slumped 267.62%.
- Aura Biosciences' Gains from Investment Securities stood at $105000.0 in 2022, then tumbled by 267.62% to -$176000.0 in 2023, then soared by 381.25% to $495000.0 in 2024, then tumbled by 60.81% to $194000.0 in 2025, then soared by 479.16% to $1.1 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.1 million (Q1 2026), $194000.0 (Q4 2025), and $285143.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 285,143.00 |
| Sep 30, 2025 | 285,143.00 |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Dec 31, 2024 | 495,000.00 |
| Dec 31, 2024 | 495,000.00 |
| Sep 30, 2024 | 976,345.00 |
| Sep 30, 2024 | 976,345.00 |
| Jun 30, 2024 | 6.05 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Dec 31, 2023 | -176,000.00 |
| Dec 31, 2023 | -176,000.00 |
| Sep 30, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.19 Mn |